🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →
S&P 500: 778.57 +0.6% NASDAQ 100: 751.27 +0.5% Dow Jones: 534.08 -0.5%

Trans-Canada Capital - Q4 2025 13F Filings

TR

Trans-Canada Capital Inc.

CIK: 0001896476
Address: Quebec, Canada Montreal 1800 Ave. Mcgill College Suite 2000
$1.74 B
Portfolio Value
7
Assets Held
Reporting Period: Q4 2025
Filing Status:
Active
Last Updated: 08/13/2026

Portfolio Summary (Q4 2025)

View Full Portfolio Analysis

Top Buys

Q4 2025
1. VOO Vanguard S&P 500 Etf
+$266.32 M
2. GDX Vaneck Gold Miners Etf
+$1.93 M

Top Sells

Q4 2025
1. FBTC Fidelity Wise Origin Bitcoin Fund
−$77.14 M
2. IBIT Ishares Bitcoin Trust Etf
−$67.67 M
3. BN Brookfield Corporation
−$12.07 M
4. XLV Health Care Select Sector Spdr Fund
−$8.2 M
5. RIVN Rivian Automotive
−$6.38 M

Asset Allocation

Stocks/ETFs
+5.64%
$1.74 B 100.00%
Options
$0 0.00%
Debt
$0 0.00%
Other
$0 0.00%

Sector Allocation (Stocks)

Trans-Canada Capital Q4 2025 Filing Summary

Trans-Canada Capital Inc. filed its 13F report for Q4 2025 on February 09, 2026. The portfolio totaled 1.74 B reflecting a +5.64% change from the prior quarter, spanning 7 assets. The top 10 holdings comprised 100.0% of the portfolio, with Financials as the largest sector allocation. Quarterly activity included 1 new positions and 5 complete exits.

Report Type

Status

Data Summary

Items:

Total Value:

Actions

Issuer Name Class Value Shares Option Type

FAQs for Trans-Canada Capital’s Q4 2025 Filing

Trans-Canada Capital submitted their Form 13F-HR for the Q4 2025 period on 02/09/2026. This was the only submission for the quarter.

In the Q4 2025 filing, Trans-Canada Capital reported a managed portfolio value of 1.74 B, consisting of 7 individual positions.

This page displays the raw filing documents. To see which stocks Trans-Canada Capital bought or sold during Q4 2025, please visit Trans-Canada Capital's Portfolio Analysis page.